<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Plasma concentrations of hepatocyte growth factor (HGF), a powerful angiogenic growth factor inducible by <z:chebi fb="5" ids="28304">heparin</z:chebi>, increase in <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e>-associated disorders such as <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> and unstable <z:mp ids='MP_0006112'>angina</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>The mechanism of this <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e>-associated HGF release, however, is unknown </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS AND RESULTS: Wistar rats received through the tail vein (1) <z:mpath ids='MPATH_458'>normal</z:mpath> saline (NS), (2) 50 micro g of the mast cell-degranulating agent CP48/80, or (3) 1000 U/kg <z:chebi fb="5" ids="28304">heparin</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Blood samples were collected at 10 minutes or 30 minutes after the injections, or from untreated rats, for measurements of HGF </plain></SENT>
<SENT sid="4" pm="."><plain>The same experiments were performed in mast cell-deficient <z:mp ids='MP_0002938'>white spotting</z:mp> (Ws) rats </plain></SENT>
<SENT sid="5" pm="."><plain>Ws rats have a small deletion of the c-kit gene and are deficient in mast cells </plain></SENT>
<SENT sid="6" pm="."><plain>Intravenous <z:chebi fb="5" ids="28304">heparin</z:chebi> immediately increased plasma HGF in both Wistar (38.02+/-2.08 ng/mL versus 1.11+/-0.70 ng/mL in untreated rats, P&lt;0.0001) and Ws rats (36.39+/-4.15 ng/mL versus 0.66+/-0.18 ng/mL in NS-treated rats, P&lt;0.0001) </plain></SENT>
<SENT sid="7" pm="."><plain>Injection of CP48/80 also increased plasma HGF in Wistar rats (9.12+/-1.11 ng/mL versus 0.65+/-0.24 ng/mL in NS group, P=0.004) but not in Ws rats (0.67+/-0.27 ng/mL versus 0.66+/-0.18 ng/mL in NS group, P=0.997) </plain></SENT>
<SENT sid="8" pm="."><plain>In a rat carotid artery microthrombus model, intra-arterial <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation increased circulating HGF in Wistar rats (2.12+/-0.70 ng/mL versus sham 0.61+/-0.15 ng/mL in sham-operated Wistar rats, P=0.0064) but not in Ws rats (0.76+/-0.33 ng/mL versus 0.21+/-0.04 ng/mL in sham-operated Ws rats, P=0.29) </plain></SENT>
<SENT sid="9" pm="."><plain>In addition, in vitro stimulation of rat peritoneal mast cells with thrombin rapidly induced degranulation in a dose-dependent manner </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: These observations indicate that mast cell degranulation stimulated by thrombin is necessary for the rapid induction of plasma HGF in intravascular <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e>-associated disorders </plain></SENT>
</text></document>